腺苷三磷酸肿瘤药敏试验在妇科肿瘤中的应用研究进展
Progress of ATP tumor chemoseusitivity assay in gynecologic cancer
摘要
由于肿瘤存在异质性及耐药性,选择敏感药物实施个体化治疗可望改善妇科肿瘤患者的预后。体外化疗药物敏感试验是目前肿瘤领域的一大研究热点。腺苷三磷酸肿瘤药物敏感试验(ATP TCA)是目前可评价率较高、检测结果与临床相关性较好的体外药敏试验方法;现综述其在妇科肿瘤领域的研究进展。
出处
《国外医学（肿瘤学分册）》
2005年第3期215-218,共4页
Foreign Medical Sciences (Cancer Section)
参考文献18
-
1Konecny G, Crohns C, Pegram M, et al. Correlation of drug response with the ATP tumor-chemosensitivity assay in primary FIGO stage Ⅲovarian cancer. Gynecol Oncol,2000,77 (2) :258-263.
-
2O' Meara AT, Sevin BU. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer. Gynecol Oncol,2001,83 (2) :334-342.
-
3Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin,2004,54(1) :8-29.
-
4Di Nicolantonio F,Neale MH,Knight LA,et al. Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer. Anticancer Drugs,2002,13 (6): 625- 630.
-
5Kurbacher CM,Cree IA,Bruckner HW,et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs, 1998,9(1) :51-57.
-
6Ng TY, Ngan HY, Cheng DK, et al. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.Gynecol Oncol,2000,76 (3) :405-408.
-
7Sharma S,Neale MH,Di Nicolantonio F,et al. Outcome of ATP- based tumor chemosensitivity assay directed chemotherapy in heavily pretreated recurrent ovarian carcinoma. BMC Cancer,2003,3 (1) :19.
-
8Breidenbach M, Rein DT, Schondorf T, et al. Hematological sideeffect profiles of individualized chemotherapy regimen for recurrent ovarian cancer. Anticancer Drugs ,2003,14 (5) :341-346.
-
9O'meara AT,Sevin BU. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT- 11 ( irinotecan). Gynecol Oncol, 1999,72 (2): 143-147.
-
10Neale MH,Charlton PA,Cree IA. Ex vivo activity of XR5000 against solid tumors. Anticancer Drugs,2000,11 (6) :471-478.
-
1卢明,刘运生.药敏试验在恶性肿瘤化疗中的应用[J].医学临床研究,2008,25(6):1129-1131. 被引量：1
-
2单彬彬,韩福才,张全卯,白艳红,郭江红.三磷酸腺苷生物荧光法在晚期肺癌二线化疗中的敏感性研究[J].山西医药杂志（下半月）,2013,42(7):750-752. 被引量：1
-
3施维,顾美皎,梁连铸,娄高峰,曾桂兰,郝巧玲,卢运萍,舒柏华,周宜开.检测三磷酸腺苷预测卵巢癌细胞株对化疗药物的敏感性[J].中华妇产科杂志,1996,31(2):79-82. 被引量：7
-
4吴春芳,李玲香.脆性组氨酸三联体基因与喉癌研究进展[J].医学综述,2008,14(8):1192-1194.
-
5吕桂芝,高燕,周立新,姚蓓,林仲翔.三磷酸腺苷对人胃癌细胞系MGC－803影响的电镜观察[J].解剖学报,1994,25(2):181-183. 被引量：2
-
6陈贝贝,钟美佐,余兴,曾佳,黄进.沙利度胺对人类非霍奇金淋巴瘤Raji细胞血管内皮生长因子的影响[J].白血病．淋巴瘤,2008,17(1). 被引量：2
-
7高虎,张方信,梁君蓉.药物诱导细胞凋亡与胃癌治疗[J].世界华人消化杂志,2000,8(7):795-796. 被引量：10
-
8俞岚,宋文庆,周蕾,武世伍,王丹娜.上皮性卵巢癌中ALDH1和ABCG2的表达及其与微血管形成的关系[J].中国病理生理杂志,2016,32(10):1807-1814. 被引量：6
-
9高玉涛,吴令英,张伟,赵丹,李宁,田海梅,王小兵,李茉,孙阳春,李楠,李晓光.三磷酸腺苷-肿瘤体外药敏试验指导复发性卵巢上皮性癌化疗的前瞻性研究[J].中华妇产科杂志,2013,48(5):358-363. 被引量：5
-
10魏文青,赵满仓,刘晶,焦娟,张艳,付瑶.MTT肿瘤药物敏感试验的方法学研究[J].临床肿瘤学杂志,2008,13(10):871-874. 被引量：18
